These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6226795)

  • 1. An analysis of 1-(2-chloroethyl)-1-nitrosourea activity at the cellular level.
    Weinkam RJ; Dolan ME
    J Med Chem; 1983 Nov; 26(11):1656-9. PubMed ID: 6226795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of carbamoylation on cell survival and DNA repair in normal human embryo cells (IMR-90) treated with various 1-(2-chloroethyl)-1-nitrosoureas.
    Sariban E; Erickson LC; Kohn KW
    Cancer Res; 1984 Apr; 44(4):1352-7. PubMed ID: 6704956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of biochemical and biological effects of four nitrosoureas with differing carbamoylating activities.
    Kann HE
    Cancer Res; 1978 Aug; 38(8):2363-6. PubMed ID: 149589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cell cycle position on the survival of 9L cells treated with nitrosoureas that alkylate, cross-link, and carbamoylate.
    Linfoot PA; Gray JW; Dean PN; Marton LJ; Deen DF
    Cancer Res; 1986 May; 46(5):2402-6. PubMed ID: 3697983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.
    Bedford P; Berger MR; Eisenbrand G; Schmähl D
    J Cancer Res Clin Oncol; 1984; 108(1):141-7. PubMed ID: 6235230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas.
    Stahl W; Krauth-Siegel RL; Schirmer RH; Eisenbrand G
    IARC Sci Publ; 1987; (84):191-3. PubMed ID: 2960614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
    Fox PA; Panasci LC; Schein PS
    Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC; Green D; Schein PS
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicity.
    Macdonald JS; Hoth D; Schein PS
    Recent Results Cancer Res; 1980; 70():83-9. PubMed ID: 6444466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased mutagenicity of chloroethylnitrosoureas in the presence of a rat liver S9 microsome mixture.
    Suling WJ; Rice LS; Shannon WM
    J Natl Cancer Inst; 1983 Apr; 70(4):767-9. PubMed ID: 6220173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.
    Zeller WJ; Eisenbrand G; Fiebig HH
    J Cancer Res Clin Oncol; 1979 Sep; 95(1):43-9. PubMed ID: 159309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
    Fujimoto S; Ogawa M
    Cancer Chemother Pharmacol; 1982; 9(3):134-9. PubMed ID: 6218931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
    Fujimoto S; Tashiro T; Ogawa M
    Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In the search for new anticancer drugs XII. Synthesis and biological evaluation of spin labeled nitrosoureas.
    Sosnovsky G; Li SW
    Life Sci; 1985 Apr; 36(15):1479-83. PubMed ID: 3982222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
    Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
    J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenic activity of nitrosourea antitumor agents.
    Franza BR; Oeschger NS; Oeschger MP; Schein PS
    J Natl Cancer Inst; 1980 Jul; 65(1):149-54. PubMed ID: 6446611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas.
    Brajtburg J; Elberg S; Schechtman KB; Medoff G
    Cancer Res; 1990 Jun; 50(11):3274-8. PubMed ID: 2334920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on the antitumor activity and the bone marrow toxicity of 1-(beta-D-glucopyranosyl)-3-(2-chloroethyl)-3-nitrosourea and 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose.
    Aoshima M; Sakurai Y
    Gan; 1977 Apr; 68(2):247-50. PubMed ID: 892299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
    Eisenbrand G
    IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.